Filter By:
Reporting
CTNPT 003: Bone and renal outcomes in tenofovir exposed infants
Bone and renal outcomes in HIV-exposed uninfected infants with perinatal exposure to tenofovir
Learn MoreCompleted
CTN 002: ddI, continued AZT
Double Blind Comparison of ddI and Continued Zidovudine (AZT) in Therapy of Patients with HIV-Related Immune Suppression: Trial results
Learn MoreReporting
CTNPT 002: SPOT Impact of counselling on sexual risk behaviours
SPOT, a rapid HIV testing intervention for MSM: measuring the impact of counselling on sexual risk behaviours
Learn MoreCompleted
CTNPT 001: Fracture case-control study in HIV
A case-control study of novel bone imaging techniques and plasma markers in HIV-infected persons with or without fragility fractures
Learn MoreCompleted
Nutritional intervention for non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) in HIV: The role of nutritional interventions
Learn MoreCompleted
Kaletra® monotherapy in HIV/HCV co-infection
A pilot, prospective, open-label study to evaluate the safety and efficacy of Kaletra® monotherapy in HIV/HCV co-infected subjects
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.